Van Bael & Bellis' team advises on patents, trade marks, and copyright enforcement matters. The group is perhaps best known for its strength in handling IP-related issues for clients in the life sciences sector. Practice head Peter L’Ecluse focuses on multi-jurisdictional patent litigation, as well as advising on counterfeiting cases in the pharmaceutical sector. Thibaut D’hulst left the firm in November 2025.
Legal 500 Editorial commentary

Key clients

  • 3Shape
  • Canon Europe
  • ECMWF
  • FCR Media
  • Gedeon Richter
  • IFPI
  • Nike
  • Sopra Steria
  • Super League Triathlon
  • UBConnect

Work highlights

Assisted Gedeon Richter with the IP aspects of its acquisition of Estera and Neuralis from Mithra Pharmaceuticals and its acquisition of BCI Pharma.
Practice head

Peter L’Ecluse